As of June 7, 2010, Amgen had eleven approved drugs for sixteen conditions (conditions lists are highly generalized; see each article for more detail):
*Aranesp (for anemia)
*Enbrel (for various forms of arthritis)
*Epogen (also known as Procrit; for anemia)
*Kepivance (for oral mucositis)
*Kineret (for rheumatoid arthritis)
*Neupogen (for neutropenia)
*Neulasta (for neutropenia)
*Vectibix (for colon cancer)
*Sensipar (for Secondary hyperparathyroidism, a mineral metabolism complication common in patients with kidney failure)
*Nplate (for chronic immune thrombocytopenic purpura)
*Prolia (for postmenopausal osteoporosis)
In other drug discovery phases (Phases I, II, III and in preclinical development), the company has twenty-three pharmacologic agents for twenty-eight conditions; nineteen of the candidates are not currently approved for any indication.
Adapted from the Wikipedia article Amgen, under the G. N. U. Free Documentation License. Please also see http://en.wikipedia.org/wiki
Amgen – Products
As of June 7, 2010, Amgen had eleven approved drugs for sixteen conditions (conditions lists are highly generalized; see each article for more detail): *Aranesp (for anemia) *Enbrel (for various forms of arthritis) *Epogen (also known as Procrit; for anemia) *Kepivance (for oral mucositis) .
If you enjoyed this article, please consider sharing it!
Related Articles
Related Videos
Phyllis cured her rheumatoid arthritis and got her life back by following a simple diet of delicious foods, no pills, side effects, or expense....
Rheumatoid arthritis is an inflammatory disease that can affect many joints in your body. Learn more about the causes, symptoms and some treatment options for...
Rheumatoid arthritis affects 1.3 million Americans. Research advances and drug development have helped control this chronic disease. Noted UCLA Rheumatology expert Dr. Michael Weisman, presents...